Related Experiment Video
Updated: Mar 2, 2026

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
AHNAK suppresses tumour proliferation and invasion by targeting multiple pathways in triple-negative breast cancer
Bo Chen1, Jin Wang1, Danian Dai1
1Department of Breast Oncology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, 651 East Dongfeng Road, Guangzhou, 510060, People's Republic of China.
Background:
AHNAK, also known as desmoyokin, is a giant protein with the molecular size of approximately 700 kDa and exerts diverse functions in different types of cancer.
Results:
In the present study, we demonstrated that AHNAK mRNA levels were down-regulated in 7 out of 8 human breast cancer cell lines, especially in triple - negative breast cancer (TNBC) cell lines. Moreover, in patients with TNBC, the expression of AHNAK gene was inversely correlated with the tumor status (P = 0.015), lymph node status (P < 0.001), lymph node (LN) infiltration (P < 0.001) and TNM stage (P < 0.001). Moreover, down-regulated AHNAK expression was considered an independent prognostic factor associated with the poor survival of patients with TNBC. Overexpression of AHNAK in two TNBC cell lines, MDA-MB-231 and BT549, suppressed the in vitro TNBC cell proliferation and colony formation, and inhibited the in vivo TNBC xenograft growth and lung metastasis. The tumor suppressing effect of AHNAK in TNBC was associated with the AKT/MAPK signaling pathway and Wnt/β-catenin pathway. Consistent results were observed when AHNAK was knockdown in BT20 and MDA-MB-435 cells.
Conclusions:
Taken together, our results suggest that AHNAK acts as a tumor suppressor that negatively regulates TNBC cell proliferation, TNBC xenograft growth and metastasis via different signaling pathways.
Insights
The AHNAK protein acts as a tumor suppressor in triple-negative breast cancer (TNBC). Its down-regulation correlates with poor prognosis, while its restoration inhibits TNBC cell growth and metastasis.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- AHNAK (desmoyokin) is a large protein implicated in various cancer functions.
- Its role in triple-negative breast cancer (TNBC) remains to be fully elucidated.
Purpose of the Study:
- To investigate the role of AHNAK in triple-negative breast cancer (TNBC).
- To determine the prognostic significance of AHNAK expression in TNBC patients.
Main Methods:
- Analysis of AHNAK mRNA levels in breast cancer cell lines and patient tumors.
- Correlation analysis between AHNAK expression and clinicopathological features in TNBC.
- In vitro and in vivo functional assays of AHNAK in TNBC cell lines.
- Investigation of signaling pathways involved in AHNAK's tumor-suppressive effects.
Main Results:
- AHNAK mRNA was down-regulated in most human breast cancer cell lines, particularly in TNBC.
- Reduced AHNAK expression correlated significantly with advanced tumor status, lymph node infiltration, and TNM stage in TNBC patients.
- AHNAK overexpression suppressed TNBC cell proliferation, colony formation, xenograft growth, and lung metastasis.
- AHNAK knockdown yielded consistent results, confirming its tumor-suppressive role.
Conclusions:
- AHNAK functions as a tumor suppressor in triple-negative breast cancer.
- Down-regulation of AHNAK is an independent prognostic factor for poor survival in TNBC patients.
- AHNAK exerts its tumor-suppressive effects by modulating the AKT/MAPK and Wnt/β-catenin signaling pathways.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Inhibition of Cdk Activity
Abnormal Proliferation

